N-3 Poly-Unsaturated Fatty Acids Shift Estrogen Signaling to Inhibit Human Breast Cancer Cell Growth

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Cao, WenQing ^a   Ma, ZhiFan ^a,d   Rasenick, Mark M ^b,c   Yeh, ShuYan ^a   Yu, JiangZhou ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

^d SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; ICOSAPENTAENOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 3; OMEGA 3 FATTY ACID; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84871687584     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052838     Document Type: Article

References (59)

1. Signori C, El-Bayoumy K, Russo J, Thompson HJ, Richie JP, et al. (2011) Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations. Cancer Res 71: 6091-6096.
2. Schley PD, Brindley DN, Field CJ, (2007) (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. The Journal of nutrition 137: 548-553.
3. Schley PD, Jijon HB, Robinson LE, Field CJ, (2005) Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast cancer research and treatment 92: 187-195.
4. Stillwell W, Shaikh SR, Zerouga M, Siddiqui R, Wassall SR, (2005) Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reproduction, nutrition, development 45: 559-579.
5. Corsetto PA, Cremona A, Montorfano G, Jovenitti IE, Orsini F, et al. (2012) Chemical-physical changes in cell membrane microdomains of breast cancer cells after omega-3 PUFA incorporation. Cell biochemistry and biophysics 64: 45-59.
6. Williams JA, Batten SE, Harris M, Rockett BD, Shaikh SR, et al. (2012) Docosahexaenoic and eicosapentaenoic acids segregate differently between raft and nonraft domains. Biophysical journal 103: 228-237.
7. Rogers KR, Kikawa KD, Mouradian M, Hernandez K, McKinnon KM, et al. (2010) Docosahexaenoic Acid Alters Epidermal Growth Factor Receptor Related Signaling by Disrupting its Lipid Raft Association. Carcinogenesis 31: 1523-1530.
8. Altenburg JD, Siddiqui RA, (2009) Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells. Mol Cancer Res 7: 1013-1020.
9. Kang KS, Wang P, Yamabe N, Fukui M, Jay T, et al. (2010) Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One 5: e10296.
10. Madak-Erdogan Z, Lupien M, Stossi F, Brown M, Katzenellenbogen BS, (2011) Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs. Mol Cell Biol 31: 226-236.
11. Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, et al. (2005) Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst 97: 1746-1759.
12. Song RX, Mor G, Naftolin F, McPherson RA, Song J, et al. (2001) Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol. J Natl Cancer Inst 93: 1714-1723.
13. Santen RJ, Fan P, Zhang Z, Bao Y, Song RX, et al. (2009) Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and-resistant breast cancer cells. Steroids 74: 586-594.
14. Corsetto PA, Montorfano G, Zava S, Jovenitti IE, Cremona A, et al. (2011) Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane. Lipids in health and disease 10: 73.
15. Dimri M, Bommi PV, Sahasrabuddhe AA, Khandekar JD, Dimri GP, (2010) Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis 31: 489-495.
16. Wu M, Harvey KA, Ruzmetov N, Welch ZR, Sech L, et al. (2005) Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int J Cancer 117: 340-348.
17. Sun H, Hu Y, Gu Z, Owens RT, Chen YQ, et al. (2011) Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway. Carcinogenesis 32: 1518-1524.
18. Chen M, Ni J, Chang HC, Lin CY, Muyan M, Yeh S, (2009) CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells. Carcinogenesis 30: 841-850.
19. Shyr CR, Tsai MY, Yeh S, Kang HY, Chang YC, et al. (2010) Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growth. Prostate 70: 190-199.
20. Yu JZ, Dave RH, Allen JA, Sarma T, Rasenick MM, (2009) Cytosolic Galpha s acts as an intracellular messenger to increase microtubule dynamics and promote neurite outgrowth. The Journal of biological chemistry 284: 10462-10472.
21. Akaogi K, Nakajima Y, Ito I, Kawasaki S, Oie SH, et al. (2009) KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha. Oncogene 28: 2894-2902.
22. Chow SK, Chan JY, Fung KP, (2004) Suppression of cell proliferation and regulation of estrogen receptor alpha signaling pathway by arsenic trioxide on human breast cancer MCF-7 cells. J Endocrinol 182: 325-337.
23. Zhang D, Jiang P, Xu Q, Zhang X, (2011) Arginine and glutamate-rich 1 (ARGLU1) interacts with mediator subunit 1 (MED1) and is required for estrogen receptor-mediated gene transcription and breast cancer cell growth. The Journal of biological chemistry 286: 17746-17754.
24. Kastrati I, Edirisinghe PD, Wijewickrama GT, Thatcher GR, (2010) Estrogen-induced apoptosis of breast epithelial cells is blocked by NO/cGMP and mediated by extranuclear estrogen receptors. Endocrinology 151: 5602-5616.
25. Jordan VC, Lewis JS, Osipo C, Cheng D, (2005) The apoptotic action of estrogen following exhaustive antihormonal therapy: a new clinical treatment strategy. Breast 14: 624-630.
26. Kelly MJ, Levin ER, (2001) Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12: 152-156.
27. Filardo EJ, Quinn JA, Frackelton AR, Bland KI, (2002) Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16: 70-84.
28. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, et al. (2004) The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. The Journal of biological chemistry 279: 27008-27016.
29. Notas G, Kampa M, Pelekanou V, Castanas E, (2012) Interplay of estrogen receptors and GPR30 for the regulation of early membrane initiated transcriptional effects: A pharmacological approach. Steroids 77: 943-950.
30. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER, (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630.
31. Thomas P, Pang Y, Filardo EJ, Dong J, (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146: 624-632.
32. Filardo EJ, Thomas P, (2005) GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 16: 362-367.
33. Prossnitz ER, Oprea TI, Sklar LA, Arterburn JB, (2008) The ins and outs of GPR30: a transmembrane estrogen receptor. J Steroid Biochem Mol Biol 109: 350-353.
34. Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M, et al. (2009) Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. Embo J 28: 523-532.
35. Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, et al. (2010) The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res 70: 1184-1194.
36. Kelly MJ, Wagner EJ, (1999) Estrogen Modulation of G-protein-coupled Receptors. Trends Endocrinol Metab 10: 369-374.
37. Stoica GE, Franke TF, Wellstein A, Czubayko F, List HJ, et al. (2003) Estradiol rapidly activates Akt via the ErbB2 signaling pathway. Mol Endocrinol 17: 818-830.
38. Evinger AJ, Levin ER, (2005) Requirements for estrogen receptor alpha membrane localization and function. Steroids 70: 361-363.
39. Filardo EJ, (2002) Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol 80: 231-238.
40. Castoria G, Migliaccio A, D'Amato L, Di Stasio R, Ciociola A, et al. (2008) Integrating signals between cAMP and MAPK pathways in breast cancer. Front Biosci 13: 1318-1327.
41. Files JA, Allen SV, Pruthi S, (2012) Hormones therapy for management of menopausal breast cancer risk. Minerva ginecologica 64: 223-230.
42. Kennedy BJ, (1962) Massive estrogen administration in premenopausal women with metastatic breast cancer. Cancer 15: 641-648.
43. Kennedy BJ, (1962) Massive estrogen administration in premenopausal women with advanced breast cancer. Cancer Chemother Rep 16: 283-284.
44. Song RX, Santen RJ, (2003) Apoptotic action of estrogen. Apoptosis 8: 55-60.
45. Ariazi EA, Cunliffe HE, Lewis-Wambi JS, Slifker MJ, Willis AL, (2011) Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time. Proc Natl Acad Sci U S A 108: 18879-18886.
46. Zivadinovic D, Gametchu B, Watson CS, (2005) Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses. Breast Cancer Res 7: R101-112.
47. Filardo EJ, Quinn JA, Bland KI, Frackelton AR, (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14: 1649-1660.
48. Pedram A, Razandi M, Levin ER, (2006) Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20: 1996-2009.
49. Aronica SM, Kraus WL, Katzenellenbogen BS, (1994) Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci U S A 91: 8517-8521.
50. Chen J, Bander JA, Santore TA, Chen Y, Ram PT, (1998) Expression of Q227L-galphas in MCF-7 human breast cancer cells inhibits tumorigenesis. Proc Natl Acad Sci U S A 95: 2648-2652.
51. Kato JY, Matsuoka M, Polyak K, Massague J, Sherr CJ, (1994) Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79: 487-496.
52. Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, (2012) The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells. Breast Cancer Res Treat 132: 449-461.
53. Kim SN, Ahn YH, Kim SG, Park SD, Cho-Chung YS, (2001) 8-Cl-cAMP induces cell cycle-specific apoptosis in human cancer cells. Int J Cancer 93: 33-41.
54. Boe R, Gjertsen BT, Doskeland SO, Vintermyr OK, (1995) 8-Chloro-cAMP induces apoptotic cell death in a human mammary carcinoma cell (MCF-7) line. Br J Cancer 72: 1151-1159.
55. Zambon AC, Wilderman A, Ho A, Insel PA, (2011) Increased expression of the pro-apoptotic protein BIM, a mechanism for cAMP/protein kinase A (PKA)-induced apoptosis of immature T cells. The Journal of biological chemistry 286: 33260-33267.
56. Thangavel M, Liu X, Sun SQ, Kaminsky J, Ostrom RS, (2009) The C1 and C2 domains target human type 6 adenylyl cyclase to lipid rafts and caveolae. Cell Signal 21: 301-308.
57. Allen JA, Yu JZ, Dave RH, Bhatnagar A, Roth BL, et al. (2009) Caveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs/adenylyl cyclase signaling. Mol Pharmacol 76: 1082-1093.
58. Allen JA, Yu JZ, Donati RJ, Rasenick MM, (2005) Beta-adrenergic receptor stimulation promotes G alpha s internalization through lipid rafts: a study in living cells. Molecular pharmacology 67: 1493-1504.
59. Allen JA, Halverson-Tamboli RA, Rasenick MM, (2007) Lipid raft microdomains and neurotransmitter signalling. Nature reviews Neuroscience 8: 128-140.